Supriya G. Mohile
Led GAP70+, which showed a geriatric assessment cuts serious chemotherapy toxicity in older patients.
Overview
Supriya Mohile was principal investigator of GAP70+, the cluster-randomised trial showing that giving oncologists a geriatric assessment with management recommendations reduces grade 3-5 toxicity in older adults with advanced cancer without compromising survival, and led the ASCO guideline recommending geriatric assessment for all patients over 65 receiving chemotherapy. She directs geriatric oncology research at Wilmot.
Pages like this
not linked directly; found by shared links- IdeaGeriatric assessment by default for every older patient, and trials that admit them
Shares GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.
- IdeaGeriatric assessment by default for every patient over 70 starting cancer treatment
Shares GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.
- IdeaDose-finding in older and frail patients, not extrapolation from fit ones
Shares GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.
- TechnologyTai chi and qigong
Shares Geriatric assessment and the tag supportive-care.
- BottleneckOlder and multimorbid patients are excluded and undertreated
Shares Wilmot Cancer Institute, University of Rochester, GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.